Omzo vs Try Ageless: Compounded GLP-1 Plans Compared
Quick verdict: Omzo focuses on clinician-guided access to compounded semaglutide and tirzepatide with prices starting at $179 and $279 respectively, while Try Ageless emphasizes three GLP-1 formats including needle-free tirzepatide oral drops from $159/mo and built-in discounts. Choose Omzo for clinician-reviewed plans and Try Ageless for format choice and lower prepaid monthly entry pricing.
Explore Omzo clinician-guided plans
Overview: Omzo vs Try Ageless at a glance
This direct comparison contrasts four main differences supported by the sources: pricing and billing model, medication formats and compound status, clinician review and prescribing process, and notable program features like bundled B12 or shipping. Both providers offer compounded GLP-1 medications prescribed by licensed U.S. clinicians. Neither provider supplies FDA approval for their compounded medications; each source explicitly states compounded products are not FDA-approved.
Pricing and billing model
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. The evidence states Omzo charges fees that include medication costs paid to compounding pharmacies, but specific month-to-month plan structures are not supplied beyond those starting prices. Try Ageless shows per-month pricing on yearly prepaid plans: semaglutide from $199/mo, tirzepatide from $249/mo, and oral drops from $159/mo, with the lowest entry price available on the prepaid yearly plan. Try Ageless also reports a built-in discount and an extra code SLIM50 that stacks for additional savings.
How pricing shapes choice
Omzo presents single starting prices and clinician-guided plan options; Try Ageless emphasizes monthly prepaid rates and built-in discounts with format-specific pricing advantages for the oral drops.
See Try Ageless formats and pricing
Medication formats and regulatory notes
Both vendors offer compounded semaglutide and tirzepatide. Omzo specifically calls out a compounded medication program prepared by state-licensed sterile compounding pharmacies and includes the regulatory note that these compounded drugs are not FDA-approved. Try Ageless sells three formats: semaglutide injection, tirzepatide injection, and needle-free tirzepatide oral drops. Try Ageless notes that the oral tirzepatide drops are an off-label compounded format and that tirzepatide is not FDA-approved in oral form. Both sources emphasize that compounded medications have not been reviewed by the FDA for safety, effectiveness, or quality.
Clinician review, prescriptions, and flexibility
Omzo connects customers with licensed U.S. providers who determine eligibility and make the final prescribing decision; the site clarifies Omzo is not a medical practice and that clinical services are provided by third party networks of licensed clinicians. Try Ageless likewise prescribes through licensed U.S. clinicians, and it states clinicians can switch a patient between semaglutide, tirzepatide, and drops under the same plan with no new consult fee. Try Ageless highlights unlimited messaging and the ability to pause or cancel plans anytime on prepaid plans.
Program features and delivery
Omzo highlights fast, discreet delivery and FSA and HSA eligibility, while stressing that medication appearance may differ from website images and that costs are included in fees collected by Omzo. Try Ageless includes B12 in every plan for energy support, free discreet shipping, plain packaging, and notes the discount is built into every plan rather than a first-month teaser. Try Ageless also claims LegitScript certification and HIPAA compliance for its pharmacy network per the source evidence.
Comparison table
| Criteria | Omzo | Try Ageless |
|---|---|---|
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | Prepaid yearly: semaglutide from $199/mo; tirzepatide from $249/mo; drops from $159/mo |
| Medication formats | Compounded semaglutide and tirzepatide (injection) | Compounded semaglutide injection, tirzepatide injection, and tirzepatide oral drops |
| Compounded status | Compounded medications prepared by state-licensed sterile compounding pharmacy; not FDA-approved | Compounded medications from state-licensed U.S. pharmacies; not FDA-approved; oral drops are off-label format |
| Clinician oversight | Clinician-guided plans reviewed by licensed U.S. providers; providers decide prescription | Licensed U.S. clinicians prescribe and can switch formats under one plan with no new consult fee |
| Shipping and extras | Fast, discreet delivery; FSA and HSA eligible; medication costs included in fees | Free discreet shipping; B12 included in every plan; discount built into plan plus code SLIM50 |
What the sources do not supply
The sources do not provide head-to-head clinical efficacy comparisons, exact month-to-month Omzo plans beyond starting prices, or state-by-state availability lists. Do not assume outcomes, insurance coverage, or universal eligibility; each provider states clinicians determine prescribing eligibility and results are not guaranteed.
Check Omzo eligibility and options
Bottom line and choice guidance
Omzo vs Try Ageless centers on clinician-guided compounded plans versus format flexibility and prepaid discounts. Omzo is positioned around clinician-reviewed GLP-1 care with stated starting prices and a compounded medication program. Try Ageless is positioned around three formats including needle-free tirzepatide drops from $159/mo on yearly plans, bundled B12, and built-in discounts.
Start with Omzo clinician-guided care
Choose Omzo if you want clinician-guided plans reviewed by licensed U.S. providers and visibility into compounded semaglutide starting at $179 or tirzepatide starting at $279. Choose Try Ageless if you prioritize the lowest advertised prepaid monthly entry price, a choice of injection or needle-free oral drops, bundled B12, and an already-applied discount plus an extra SLIM50 code. Remember that both offer compounded medications that are not FDA-approved and that clinicians determine prescription eligibility.